tetano
Editor, Senior Moderator
Am J Infect Control
. 2022 Jul 25;S0196-6553(22)00575-2.
doi: 10.1016/j.ajic.2022.07.019. Online ahead of print.
Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: lessons learned
Fareed Khawaja[SUP] 1 [/SUP], Krithika Srinivasan[SUP] 1 [/SUP], Amy Spallone[SUP] 1 [/SUP], Adina Feldman[SUP] 1 [/SUP], Sherry Cantu[SUP] 1 [/SUP], Ella Ariza-Heredia[SUP] 1 [/SUP], Tanya Dvordak[SUP] 1 [/SUP], Amin Alousi[SUP] 2 [/SUP], Sairah Ahmed[SUP] 3 [/SUP], Marina George[SUP] 4 [/SUP], Elizabeth Frenzel[SUP] 1 [/SUP], Micah Bhatti[SUP] 5 [/SUP], Roy F Chemaly[SUP] 6 [/SUP]
Affiliations
Abstract
Background: The spread of coronavirus disease 2019 (COVID-19) in health care settings endangers patients with cancer. As knowledge of the transmission of COVID-19 emerged, strategies for preventing nosocomial COVID-19 were updated. We describe our early experience with nosocomial respiratory viral infections (RVIs) at a cancer center in the first year of the pandemic (March 2020-March 2021).
Methods: Nosocomial RVIs were identified through our infection control prospective surveillance program, which conducted epidemiologic investigations of all microbiologically documented RVIs. Data was presented as frequencies and percentages or medians and ranges.
Results: A total of 35 of 3944 (0.9%) documented RVIs were determined to have been nosocomial acquired. Majority of RVIs were due to SARS CoV-2 (13/35; 37%) or by rhinovirus/enterovirus (12/35; 34%). A cluster investigation of the first 3 patients with nosocomial COVID-19 determined that transmission most likely occurred from employees to patients. Five patients (38%) required mechanical ventilation and 4 (31%) died during the same hospital encounter.
Conclusion: Our investigation of the cluster led to enhancement of our infection control measures. The implications of COVID-19 vaccination on infection control policies is still unclear and further studies are needed to delineate its impact on the transmission of COVID-19 in a hospital setting.
Keywords: COVID-19; Cancer; Nosocomial; SARS CoV-2; hospital-associated transmission; respiratory viruses.
. 2022 Jul 25;S0196-6553(22)00575-2.
doi: 10.1016/j.ajic.2022.07.019. Online ahead of print.
Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: lessons learned
Fareed Khawaja[SUP] 1 [/SUP], Krithika Srinivasan[SUP] 1 [/SUP], Amy Spallone[SUP] 1 [/SUP], Adina Feldman[SUP] 1 [/SUP], Sherry Cantu[SUP] 1 [/SUP], Ella Ariza-Heredia[SUP] 1 [/SUP], Tanya Dvordak[SUP] 1 [/SUP], Amin Alousi[SUP] 2 [/SUP], Sairah Ahmed[SUP] 3 [/SUP], Marina George[SUP] 4 [/SUP], Elizabeth Frenzel[SUP] 1 [/SUP], Micah Bhatti[SUP] 5 [/SUP], Roy F Chemaly[SUP] 6 [/SUP]
Affiliations
- PMID: 35901993
- DOI: 10.1016/j.ajic.2022.07.019
Abstract
Background: The spread of coronavirus disease 2019 (COVID-19) in health care settings endangers patients with cancer. As knowledge of the transmission of COVID-19 emerged, strategies for preventing nosocomial COVID-19 were updated. We describe our early experience with nosocomial respiratory viral infections (RVIs) at a cancer center in the first year of the pandemic (March 2020-March 2021).
Methods: Nosocomial RVIs were identified through our infection control prospective surveillance program, which conducted epidemiologic investigations of all microbiologically documented RVIs. Data was presented as frequencies and percentages or medians and ranges.
Results: A total of 35 of 3944 (0.9%) documented RVIs were determined to have been nosocomial acquired. Majority of RVIs were due to SARS CoV-2 (13/35; 37%) or by rhinovirus/enterovirus (12/35; 34%). A cluster investigation of the first 3 patients with nosocomial COVID-19 determined that transmission most likely occurred from employees to patients. Five patients (38%) required mechanical ventilation and 4 (31%) died during the same hospital encounter.
Conclusion: Our investigation of the cluster led to enhancement of our infection control measures. The implications of COVID-19 vaccination on infection control policies is still unclear and further studies are needed to delineate its impact on the transmission of COVID-19 in a hospital setting.
Keywords: COVID-19; Cancer; Nosocomial; SARS CoV-2; hospital-associated transmission; respiratory viruses.